Catalyst Crew Technologies Corp. (OTC: CCTC), a digital health and artificial intelligence technology company, announced today that it has established an operating presence in Venezuela through a wholly owned subsidiary. The move is part of the company's broader strategy to expand its healthcare technology initiatives in Latin America, focusing on telehealth infrastructure and AI-powered analytics.
The subsidiary will facilitate local operations, infrastructure development, and the planned deployment of the company's digital health platforms, including services such as remote patient monitoring and AI-enabled healthcare analytics. Management believes that this presence provides a foundation for pilot programs and collaboration with healthcare providers within the country.
The company's AI healthcare platform includes modular systems like CardioAI, PulmoAI, and NeuroAI, which are intended to be integrated into its broader healthcare services infrastructure. Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated: "Establishing a local operating presence is an important step in executing our regional strategy. We believe that combining artificial intelligence-driven healthcare technologies with localized healthcare infrastructure can support more accessible and efficient delivery of medical services."
Catalyst Crew Technologies intends to prioritize market development in Latin America, where technology-enabled healthcare solutions may help expand access to medical services, improve diagnostic capabilities, and support more efficient healthcare delivery. The company will continue evaluating opportunities to expand its presence in the region while advancing its digital health and AI platform initiatives.
For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
